SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Phillips K, Clauw DJ. Central pain mechanisms in chronic pain states: maybe it is all in their head. Best Pract Res Clin Rheumatol 2011;25:14154.
  • 2
    Sprott H, Salemi S, Bradley LA, Alarcon GS, Oh SJ, Michel BS, et al. Increased DNA fragmentation and ultrastructural changes in fibromyalgia muscle fibers. Ann Rheum Dis 2004;63:24551.
  • 3
    Ulas UH, Unlu E, Hamamcioglu K, Odabasi Z, Cakci A, Vural O. Dysautonomia in fibromyalgia syndrome: sympathetic skin responses and RR interval analysis. Rheumatol Int 2006;26:3837.
  • 4
    Caro XJ. Is there an immunologic component to the fibrositis syndrome?Rheum Dis Clin North Am 1989;15:16986.
  • 5
    Buskila D, Sarzi-Puttini P. Fibromyalgia and autoimmune diseases: the pain behind autoimmunity. Isr Med Assoc J 2008;10:778.
  • 6
    Caro XJ, Winter EF, Dumas A. A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy (CIDP) and appear to respond to IVIg. Rheumatology (Oxford) 2008;47:20811.
  • 7
    Melzack R, Katz J. Pain assessment in adult patients. In: McMahon SB, Koltzenburg M, editors.Wall and Melzack's textbook of pain. 5th ed.Philadelphia:Elsevier;2005. p.291304.
  • 8
    Martinez-Lavin M, Lopez S, Medina M, Nava A. Use of the Leeds assessment of neuropathic symptoms and signs questionnaire in patients with fibromyalgia. Semin Arthritis Rheum 2003;32:40711.
  • 9
    Simms RW, Goldenberg DL. Symptoms mimicking neurologic disorders in fibromyalgia syndrome. J Rheumatol 1988;15:12713.
  • 10
    Koroschetz J, Rehm SE, Gockel U, Brosz M, Freynhagen R, Tolle TR, et al. Fibromyalgia and neuropathic pain: differences and similarities. A comparison of 3057 patients with diabetic painful neuropathy and fibromyalgia. BMC Neurol 2011;11:55.
  • 11
    Hays AP. Utility of skin biopsy to evaluate peripheral neuropathy. Curr Neurol Neurosci Rep 2010;10:1017.
  • 12
    Kennedy WR, Wendelschafer-Crabb G, Polydefkis M, McArthur JC. Chapter 34: Pathology and quantitation of cutaneous innervation. In: Dyck PJ, Thomas PK, editors.Peripheral neuropathy. 4th ed.Philadelphia:Elsevier Saunders;2005. p.86995.
  • 13
    Chiang MC, Lin YH, Pan CL, Tseng TJ, Lin WM, Hsieh ST. Cutaneous innervation in chronic inflammatory demyelinating polyneuropathy. Neurology 2002;59:10948.
  • 14
    Herrmann DN, Griffin JW, Hauer P, Cornblath DR, McArthur JC. Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology 1999;53:163440.
  • 15
    Caro XJ, Winter E. Evidence of abnormal epidermal nerve fiber density (ENFD) in fibromyalgia [abstract].Arthritis Rheum 2008;58 Suppl:S388.
  • 16
    Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:16072.
  • 17
    DeJong RN.The neurologic examination: incorporating the fundamentals of neuroanatomy and neurophysiology. 4th ed.Cambridge:Harper & Row;1979. p.4449,67–8.
  • 18
    Chong PH, Boskovich A, Stevkovic N, Bartt RE. Statin-associated peripheral neuropathy: review of the literature. Pharmacotherapy 2004;24:1194203.
  • 19
    Kassem HS, Azar ST, Zantout MS, Sawaya RA. Hypertriglyceridemia and peripheral neuropathy in neurologically asymptomatic patients. Neuro Endocrinol Lett 2005;26:7759.
  • 20
    Alguire PC, Mathes BM. Skin biopsy techniques for the internist. J Gen Intern Med 1998;13:4654.
  • 21
    Ebenezer GJ, Hauer P, Gibbons C, McArthur JC, Polydefkis M. Assessment of epidermal nerve fibers: a new diagnostic and predictive tool for peripheral neuropathies. J Neuropathol Exp Neurol 2007;66:105973.
  • 22
    Devigili G, Tugnoli V, Penza P, Camozzi F, Lombardi R, Melli G, et al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain 2008;131:191225.
  • 23
    Moalem G, Tracey DJ. Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev 2006;51:2404.
  • 24
    Thacker MA, Clark AK, Marchand F, McMahon SB. Pathophysiology of peripheral neuropathic pain: immune cells and molecules. Anesth Analg 2007;105:83847.
  • 25
    Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al, and the European Study Group on Classification Criteria for Sjögren's Syndrome.Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 2002;61:5548.
  • 26
    Chai J, Herrmann DN, Stanton M, Barbano RL, Logigian EL. Painful small-fiber neuropathy in Sjögren syndrome. Neurology 2005;65:9257.
  • 27
    Barton A, Whorwell PJ, Marshall D. Increased prevalence of sicca complex and fibromyalgia in patients with irritable bowel syndrome. Am J Gastroenterol 1999;94:1898901.
    Direct Link:
  • 28
    McArthur JC, Stocks EA, Hauer P, Cornblath DR, Griffin JW. Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol 1998;55:151320.
  • 29
    Lauria G, Bakkers M, Schmitz C, Lombardi R, Penza P, Devigili G, et al. Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J Peripher Nerv Syst 2010;15:2027.
  • 30
    Lauria G, Holland N, Hauer P, Cornblath DR, Griffin JW, McArthur JC. Epidermal innervation: changes with aging, topographic location, and in sensory neuropathy. J Neuro Sci 1999;164:1728.
  • 31
    Thompson PD, Thomas PK. Clinical patterns of peripheral neuropathy. In: Dyck PJ, Thomas PK, editors.Peripheral neuropathy.Philadelphia:Elsevier;2005. p.113761.
  • 32
    Littlejohn GO, Weinstein C, Helme RD. Increased neurogenic inflammation in fibrositis syndrome. J Rheumatol 1987;14:10225.
  • 33
    Vaeroy H, Qiao ZG, Morkrid L, Forre O. Altered sympathetic nervous system response in patients with fibromyalgia (fibrositis syndrome). J Rheumatol 1989;16:14605.
  • 34
    Caro XJ. Immunofluorescent detection of IgG at the dermal– epidermal junction in patients with apparent primary fibrositis syndrome. Arthritis Rheum 1984;27:11749.
  • 35
    Dinerman H, Goldenberg DL, Felson DT. A prospective evaluation of 118 patients with the fibromyalgia syndrome: prevalence of Raynaud's phenomenon, sicca symptoms, ANA, low complement, and Ig deposition at the dermal-epidermal junction. J Rheumatol 1986;13:36873.
  • 36
    Enestrom S, Bengtsson A, Frodin T. Dermal IgG deposits and increase of mast cells in patients with fibromyalgia: relevant findings or epiphenomena?Scand J Rheumatol 1997;26:30813.
  • 37
    Blanco I, Beritze N, Arguelles M, Carcaba V, Fernandez F, Janciauskiene S, et al. Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients. Clin Rheumatol 2010;29:140312.
  • 38
    Caro XJ, Zuraw BI. Further evidence of high molecular weight kininogen cleavage in blister fluid of patients with primary fibrositis syndrome [abstract].Arthritis Rheum 1994;37 Suppl:S350.
  • 39
    Kim SH, Kim DH, Oh DH, Clauw DJ. Characteristic electron microscopic findings in the skin of patients with fibromyalgia: preliminary study. Clin Rheumatol 2008;27:40711.
  • 40
    Ribel-Madsen S, Gronemann ST, Bartels EM, Danneskiold-Samsoe B, Bliddal H. Collagen structure in skin from fibromyalgia patients. Int J Tissue React 2005;27:7582.
  • 41
    Pay S, Calguneri M, Caliskaner Z, Dinc A, Apras S, Ertenli I, et al. Evaluation of vascular injury with proinflammatory cytokines, thrombomodulin and fibronectin in patients with primary fibromyalgia. Nagoya J Med Sci 2000;63:11522.
  • 42
    Salemi S, Rethage J, Wollina U, Michel BA, Gay RE, Gay SG, et al. Detection of interleukin 1β (IL-1β), IL-6, and tumor necrosis factor-α in skin of patients with fibromyalgia. J Rheumatol 2003;30:14650.
  • 43
    Burda CD, Cox FR, Osborne P. Histocompatibility antigens in the fibrositis (fibromyalgia) syndrome. Clin Exp Rheumatol 1986;4:3558.
  • 44
    Jian-Xin L, Leonard WJ. Interleukin-2. In: Thomson AW, Lotze MT, editors.The cytokine handbook. 4th ed.New York:Academic Press;2003. p.16799.
  • 45
    Rubin LA, Nelson DL. The soluble interleukin-2 receptor: biology, function, and clinical application. Ann Intern Med 1990;113:61927.
  • 46
    Maurer M, Toyka KV, Gold R. Cellular immunity in inflammatory autoimmune neuropathies. Rev Neurol (Paris) 2002;158:S715.
  • 47
    Bazzichi L, Rossi A, Massimetti G, Giannaccini G, Guiliano T, De Feo F, et al. Cytokine patterns in fibromyalgia and their correlations with clinical manifestations. Clin Exp Rheumatol 2007;25:22530.
  • 48
    Wallace DJ, Margolin K, Waller P. Fibromyalgia and interleukin-2 therapy for malignancy. Ann Intern Med 1988;108:909.
  • 49
    Uceyler N, Kafke W, Riediger N, He L, Necula G, Toyka KV, et al. Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy. Neurology 2010;74:180613.
  • 50
    Caro XJ. Fibromyalgia: evaluation and therapy of a neuroimmune disorder. In: Mahmoudi M, editor.Challenging cases in rheuma tology and diseases of the immune system.New York:Springer;2013. p.25784.
  • 51
    Uceyler N, Zeller D, Kahn AK, Kewenig S, Kittel-Schneider S, Schmid A, et al. Small fibre pathology in patients with fibromyalgia syndrome. Brain 2013;136:185767.
  • 52
    Oaklander L, Klein MM. Evidence of small-fiber polyneuropathy in unexplained, juvenile-onset, widespread pain syndrome. Pediatrics 2013;131:e1091100.
  • 53
    Moalem G, Tracey DJ. Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev 2006;51:24064.